Complement C5 inhibition as a Novel Therapeutic Approach in Severe Pre-eclampsia
Mayo Clin Proc
.
2022 Aug;97(8):1580-1583.
doi: 10.1016/j.mayocp.2022.06.005.
Authors
Andrea Kattah
1
,
Aleksandra Kukla
1
,
Ronald Go
1
,
Linda Szymanski
1
,
Karl A Nath
1
,
Vesna Garovic
1
Affiliation
1
Mayo Clinic Rochester, MN USA.
PMID:
35933144
DOI:
10.1016/j.mayocp.2022.06.005
No abstract available
Publication types
Letter
MeSH terms
Complement Activation
Complement C5*
Female
Humans
Pre-Eclampsia* / drug therapy
Pregnancy
Substances
Complement C5